The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•24 June 2026•

1 min read

J&J Invests $1 Billion to Expand Contact Lens Production in Florida

Key Facts

1Johnson & Johnson is investing over $1 billion to construct a new contact lens manufacturing plant in Jacksonville, Florida.

2The project is part of a larger $55 billion investment plan in U.S. manufacturing, R&D, and technology through 2029.

3The new facility is expected to be fully operational by 2028, supporting the production of Acuvue contact lenses.

Johnson & Johnson is investing over $1 billion to construct a new contact lens manufacturing plant in Jacksonville, Florida. The project is part of a larger $55 billion investment plan in U.S. manufacturing, R&D, and technology through 2029. The new facility is expected to be fully operational by 2028, supporting the production of Acuvue contact lenses and enhancing the company's packaging and distribution capabilities.

This move comes amid intensifying competition in the healthcare sector, as JNJ seeks to bolster supply chain resilience against peers like Alcon and Bausch + Lomb. Per market data, these massive investments reflect a strategic shift toward localizing advanced manufacturing and reducing reliance on external suppliers, particularly as global demand for eye care products continues to grow.

JNJ stock stood at $240.47 (close June 24, 2026), having reached an intraday high of $243.04. Investors are closely monitoring how these capital expansions will impact long-term operating margins. Looking ahead at the economic calendar, traders are watching for the Philadelphia Fed Manufacturing Index release for broader signals regarding the U.S. industrial environment.